Stockscreener 앱 받기
181.80
0.75%
1.35
시간 외 거래:
181.80
전일 마감가:
$180.45
열려 있는:
$180.72
하루 거래량:
601.05K
Relative Volume:
0.60
시가총액:
$11.19B
수익:
$4.27B
순이익/손실:
$-356.15M
주가수익비율:
-30.45
EPS:
-5.9702
순현금흐름:
$1.19B
1주 성능:
+0.82%
1개월 성능:
+7.20%
6개월 성능:
+41.70%
1년 성능:
+27.97%
1일 변동 폭
$178.40
$183.51
1주일 범위
$177.58
$184.69
52주 변동 폭
$95.49
$198.00
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
명칭
Jazz Pharmaceuticals Plc
전화
353-1-634-7800
주소
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Compare JAZZ vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
181.80 | 11.11B | 4.27B | -356.15M | 1.19B | -5.9702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-27 | 개시 | Barclays | Overweight |
| 2025-11-24 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-07-15 | 개시 | Deutsche Bank | Buy |
| 2025-03-07 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-26 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | 개시 | Goldman | Buy |
| 2024-01-03 | 개시 | Robert W. Baird | Outperform |
| 2023-11-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-29 | 개시 | Raymond James | Mkt Perform |
| 2023-06-12 | 재개 | Wells Fargo | Equal Weight |
| 2022-12-09 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-06-14 | 개시 | UBS | Buy |
| 2022-04-06 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-11-19 | 재개 | Goldman | Buy |
| 2021-10-07 | 재개 | Jefferies | Buy |
| 2021-10-05 | 개시 | Citigroup | Buy |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-05-19 | 재개 | JP Morgan | Overweight |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2021-02-05 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-11-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-14 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-08-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | 개시 | Jefferies | Buy |
| 2020-03-12 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | 개시 | Goldman | Neutral |
| 2019-08-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2018-12-14 | 개시 | Wolfe Research | Peer Perform |
| 2018-11-08 | 재확인 | B. Riley FBR | Buy |
| 2018-08-08 | 재확인 | Stifel | Buy |
| 2018-07-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | 재확인 | H.C. Wainwright | Neutral |
| 2018-03-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Jazz Pharmaceuticals Plc 주식(JAZZ)의 최신 뉴스
Piper Sandler Maintains Overweight Rating for JAZZ, Raises Price Target | JAZZ Stock News - GuruFocus
Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $232.00 Price Target at Piper Sandler - MarketBeat
A Look At Jazz Pharmaceuticals (JAZZ) Valuation As New Oncology Data Heads To The 2026 AACR Meeting - simplywall.st
Jazz Pharmaceuticals plc (JAZZ) reports $1.2 billion Q4 revenue, beats $1.17B estimate - MSN
Is the options market predicting a spike in Jazz Pharmaceuticals stock? - MSN
Jazz Pharmaceuticals plc Denmark Finland France Germany Netherlands Sweden United Kingdom Ireland - AD HOC NEWS
Is Jazz Pharmaceuticals (JAZZ) one of the best cheap biotech stocks to buy now? - MSN
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting - Toronto Star
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026 - PR Newswire
Faithward Advisors LLC Increases Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Aug Swings: Can Jazz Pharmaceuticals plc ride the EV wave2026 Major Catalysts & Expert-Curated Trade Recommendations - baoquankhu1.vn
Fundamentals Check: Can Jazz Pharmaceuticals plc ride the EV waveDip Buying & High Conviction Buy Zone Picks - baoquankhu1.vn
Holocene Advisors LP Acquires 135,367 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Ameriprise Financial Inc. Cuts Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Buybacks Report: Can Jazz Pharmaceuticals plc expand its profit margins2026 PostEarnings & Growth Oriented Trade Recommendations - baoquankhu1.vn
Iron Triangle Partners LP Makes New $19.77 Million Investment in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Aristotle Capital Management LLC - MarketBeat
AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead? - TradingView
Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by Bank of Montreal Can - MarketBeat
Jazz Pharmaceuticals (JAZZ) Price Forecast: Multi-Year Base Signals Breakout Potential - FXEmpire
Jazz Pharmaceuticals at Barclays Conference: Strategic Growth Insights By Investing.com - Investing.com South Africa
Jazz Pharmaceuticals at Barclays Conference: Strategic Growth Insights - Investing.com Nigeria
Capital World Investors Increases Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Crossmark Global Holdings Inc. Sells 10,433 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Revenue And Supportive Barclays Commentary - simplywall.st
Jazz Pharmaceuticals Stock at $185: Here’s Why Analysts See a New All-Time High in 2026 - TIKR.com
Jazz’s 2025 Net Loss and 2026 Outlook Might Change The Case For Investing In JAZZ - simplywall.st
Jazz Pharmaceuticals (NASDAQ:JAZZ) CAO Sells $235,443.78 in Stock - MarketBeat
Tax-withholding share disposition by Jazz Pharmaceuticals (JAZZ) director - Stock Titan
Jazz Pharmaceuticals (JAZZ) CFO reports tax-withholding share disposition - Stock Titan
Jazz Pharmaceuticals (JAZZ) EVP has 2,503 shares withheld to cover RSU taxes - Stock Titan
Jazz Pharmaceuticals (JAZZ) SVP Patricia Carr reports share sales - Stock Titan
Jazz Pharmaceuticals (JAZZ) CEO has shares withheld to cover RSU taxes - Stock Titan
Barclays reiterates Jazz Pharmaceuticals stock rating on CNS strength - Investing.com Nigeria
Patricia Carr (NASDAQ: JAZZ) files Form 144 showing recent share sales - Stock Titan
JAZZ or ACAD: Which Is the Better Value Stock Right Now? - Yahoo Finance
S&P 500 Futures Fall in Premarket Trading; Jazz Pharmaceuticals, Live Nation Ent Lead - Barron's
American Century Companies Inc. Sells 36,599 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Victory Capital Management Inc. - MarketBeat
Rhenman & Partners Asset Management AB Cuts Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Is Jazz Pharmaceuticals (JAZZ) Still Attractive After Recent Share Price Strength - Yahoo Finance
Jazz Pharmaceuticals Revenue Record Puts Focus On Zanidatamab And Valuation - simplywall.st
Neo Ivy Capital Management Takes $1.84 Million Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
JAZZ Should I Buy - Intellectia AI
Deutsche Bank Adjusts Jazz Pharmaceuticals Price Target to $226 From $225, Maintains Buy Rating - marketscreener.com
GW&K Investment Management LLC Sells 17,849 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Mixed Recent Returns And A 5.7% Undervaluation Estimate - simplywall.st
Insider Sell: Bruce Cozadd Sells 6,000 Shares of Jazz Pharmaceuticals PLC (JAZZ) - GuruFocus
JAZZ SEC FilingsJazz Pharmaceuticals Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Jazz Pharmaceuticals Plc (JAZZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):